Clozapine N-oxide dihydrochloride, Tocris Bioscience, 50mg, >99%
|
Clozapine N-oxide dihydrochloride, Tocris Bioscience, 50mg, >99% assay, water soluble salt of Clozapine N-oxide (Cat. No.4936), activator of muscarinic DREADDs, improved bioavailability, observed MW: 415.74, C18H19ClN4O.2HCl
|
2946-632950
|
EA
|
|
(+)-Bicuculline, GABAA antagonist, 50mg, Tocris Bioscience
|
(+)-Bicuculline, classical GABAA antagonist, 50mg, Tocris Bioscience, Molecular Weight: 367.357, Percent Purity: >99%, CAS: 485-49-4, ChEBI: CHEBI:3092, Formula Weight: 367.36, InChI Key: IYGYMKDQCDOMRE-ZWKOTPCHSA-N
|
2946-013050
|
EA
|
|
NVP 231, CerK inhibitor, 50mg, Tocris Bioscience
|
NVP 231, potent, selective and reversible ceramide kinase inhibitor (IC50 12 nM in vitro), selectivity over sphingosine kinases and other lipid kinases, 50mg, purity >98%, CAS: 362003-83-6, Molecular Weight: 431.554, C25H25N3O2S
|
2946-396050
|
EA
|
|
Forskolin, adenylyl cyclase activator, 50mg, >98%, Tocris Bioscience
|
Forskolin, 50mg, >98%, adenylyl cyclase activator, cell-permeable, reversible, rapid (EC50=0.5M), C22H34O7, CAS 66575-29-9, CHEBI:42471, 410.51, Tocris Bioscience
|
2946-109950
|
EA
|
|
SR 95531 hydrobromide, GABAA antagonist, 50mg, Tocris Bioscience
|
SR 95531 hydrobromide, 50mg, selective competitive GABAA antagonist, IC50 200 nM, Ki 150 nM, purity >98%, CAS 104104-50-9, molecular weight 368.231, Tocris Bioscience
|
2946-126250
|
EA
|
|